Catalyst Funds Management Pty »

Humacyte shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-06-30 $162k 208k 0.78

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Bloom Energy Corp Ordinary Shares - Class A (BE)
Intel Corp. Ordinary Shares (INTC)
Microsoft Corporation Ordinary Shares (MSFT)
Credo Technology Group Holding Ordinary Shares (CRDO)
Lilly Ordinary Shares (LLY)
Vertiv Holdings Ordinary Shares - Class A (VRT)
Sterling Infrastructure Ordinary Shares (STRL)
Amazon.com Ordinary Shares (AMZN)
Qualcomm Ordinary Shares (QCOM)
Salesforce Ordinary Shares (CRM)
IonQ Ordinary Shares (IONQ)
Nextpower Ordinary Shares - Class A (NXT)
TTM Technologies Ordinary Shares (TTMI)
Fabrinet Ordinary Shares (FN)

View all positions for Catalyst Funds Management Pty

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte